Synonyms: 1263W94 | benzimidavir | Camvia® | G1263 | GW-1263 | Livtencity®
maribavir is an approved drug (FDA (2021), EMA (2022))
Compound class:
Synthetic organic
Comment: Maribavir is an orally bioavailable benzimidazole L-riboside that inhibits cytomegalovirus (CMV) pUL97 kinase with nM potency in vitro [1]. It inhibits viral replication.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (2021) | EMA (2022) |
IUPAC Name ![]() |
(2S,3S,4R,5S)-2-[5,6-dichloro-2-(propan-2-ylamino)benzimidazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol |
International Nonproprietary Names ![]() |
|
INN number | INN |
7812 | maribavir |
Synonyms ![]() |
1263W94 | benzimidavir | Camvia® | G1263 | GW-1263 | Livtencity® |
Database Links ![]() |
|
CAS Registry No. | 176161-24-3 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL515408 |
DrugBank Ligand | DB06234 |
GtoPdb PubChem SID | 472319172 |
PubChem CID | 471161 |
Search Google for chemical match using the InChIKey | KJFBVJALEQWJBS-XUXIUFHCSA-N |
Search Google for chemicals with the same backbone | KJFBVJALEQWJBS |
Search PubMed clinical trials | maribavir |
Search PubMed titles | maribavir |
Search PubMed titles/abstracts | maribavir |
UniChem Compound Search for chemical match using the InChIKey | KJFBVJALEQWJBS-XUXIUFHCSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | KJFBVJALEQWJBS-XUXIUFHCSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Maribavir (links to external site)
Cat. No. HY-16305 |